The placebo response in medicine: minimize, maximize or personalize?
The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Abstract
Our understanding of the mechanisms mediating or moderating the placebo response to medicines has grown substantially over the past decade and offers the opportunity to capitalize on its benefits in future drug development as well as in clinical practice. In this article, we discuss three strategies that could be used to modulate the placebo response, depending on which stage of the drug development process they are applied. In clinical trials the placebo effect should be minimized to optimize drug-placebo differences, thus ensuring that the efficacy of the investigational drug can be truly evaluated. Once the drug is approved and in clinical use, placebo effects should be maximized by harnessing patients' expectations and learning mechanisms to improve treatment outcomes. Finally, personalizing placebo responses - which involves considering an individual's genetic predisposition, personality, past medical history and treatment experience - could also maximize therapeutic outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This might be due to patients' expectations of benefits in clinical trials with novel substances, behavioral conditioning in research settings, or the striking overlap in neuroanatomical substrates between affected brain regions in MDD and placebo response [161]”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [161]
Citations
Cites
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
Moseley, J. B., O'Malley, K., Petersen, N. J., Menke, T. J., Brody, B. A., Kuykendall, D. H., Hollingsworth, J. C., Ashton, C. M., & Wray, N. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013259 · Cited by 2,149
Biological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196
THE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius, C. A. (2002) · JAMA · doi:10.1001/jama.288.4.462 · Cited by 1,077
A New Design for Randomized Clinical Trials
Zelen, M. (1979) · New England Journal of Medicine · doi:10.1056/nejm197905313002203 · Cited by 1,055
Behaviorally Conditioned Immunosuppression
Ader, R., & Cohen, N. (1975) · Psychosomatic Medicine · doi:10.1097/00006842-197507000-00007 · Cited by 1,018
Research works printed but not linked: 1
- Kaptchuk, T. J. et al. Do “placebo responders” exist? Contemp. Clin. Trials. 29, 587–595 (2008). · DOI
Cited by
Items 201–300 of 674
Zhang, H., Zhou, L., Wei, H., Lu, X., & Hu, L. (2017) · Journal of Pain Research · doi:10.2147/jpr.s147970 · Cited by 30
The Influence of Expectation on Nondeceptive Placebo and Nocebo Effects
Wei, H., Zhou, L., Zhang, H., Chen, J., Lu, X., & Hu, L. (2018) · Pain Research and Management · doi:10.1155/2018/8459429 · Cited by 32
Can knowledge of Placebo and Nocebo Mechanisms Help Improve Randomized Clinical Trials?
Carlino, E., & Vase, L. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.01.012 · Cited by 34
Traditional and Innovative Experimental and Clinical Trial Designs and Their Advantages and Pitfalls
Weimer, K., & Enck, P. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_14 · Cited by 32
Self-citationKisaalita, N. R., Staud, R. M., Hurley, R. W., & Robinson, M. (2014) · Pain · doi:10.1016/j.pain.2014.09.029 · Cited by 31
“Substantial evidence highlights the utility of placebo analgesic effects—real, potentially potent events mediated by psychological and neurobiological factors—for reducing pain [12].”
BackgroundOptimizing expectations and distraction leads to lower cortisol levels after acute stress
Salzmann, S., Euteneuer, F., Strahler, J., Laferton, J. A. C., Nater, U. M., & Rief, W. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.12.011 · Cited by 28
“However, approaches to utilize expectations to improve outcomes have seldom been attempted (Enck et al., 2013).”
BackgroundSelf-citationThe effects of placebos and nocebos on physical performance
Carlino, E., Piedimonte, A., & Frisaldi, E. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_9 · Cited by 28
Hasuo, H., Kanbara, K., Sakuma, H., & Fukunaga, M. (2018) · BioPsychoSocial Medicine · doi:10.1186/s13030-018-0135-y · Cited by 28
Describing deprescribing trials better: an elaboration of the CONSORT statement
Blom, J. W., Muth, C., Glasziou, P., McCormack, J. P., Perera, R., Poortvliet, R. K. E., Numans, M. E., Thürmann, P., Thiem, U., Thio, S. L., et al. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.07.011 · Cited by 28
“It is common and sometimes required to use placebo or sham interventions as a comparator in randomized controlled trials to control for the placebo and nocebo effect to detect beneficial effects as well as the adverse effects of the actual treatment [24,25].”
BackgroundSuper Placebos: A Feasibility Study Combining Contextual Factors to Promote Placebo Effects
Olson, J. A., Lifshitz, M., Raz, A., & Veissière, S. P. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.644825 · Cited by 35
“Although researchers have identified various contextual factors that modulate placebo effects (8, 20, 21), relatively little research tests how these factors may be combined.”
BackgroundHahn, A., Göhler, A. C., Hermann, C., & Winkler, A. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.02.043 · Cited by 28
Intra-articular Therapies for Knee Osteoarthritis: Current Update
Oo, W. M., & Hunter, D. J. (2023) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-023-00207-x · Cited by 29
Nocebo Effects and Experimental Models in Visceral Pain
Elsenbruch, S., & Labrenz, F. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.01.010 · Cited by 30
Rossettini, G., Palese, A., Geri, T., Mirandola, M., Tortella, F., & Testa, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00478 · Cited by 33
Anna, G. J., Rheker, J., Julia, W., Lea, R., & Rief, W. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.070 · Cited by 32
Self-citationBryant, J. E., Frölich, M. A., Tran, S., Reid, M. A., Lahti, A. C., & Kraguljac, N. V. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.07.008 · Cited by 31
“A study arm with an active placebo could mitigate these concerns (Enck et al., 2013), but any drug producing similar side effects could also confound imaging data, making interpretation of findings difficult.”
BackgroundThe Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases
Enck, P., & Klosterhalfen, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.641436 · Cited by 28
“We will also abstain from discussing the option of “harnessing the placebo response” in clinical routine, beyond RCT (Enck et al., 2013), or implementing “open-label placebo” treatment (Ballou et al.”
MethodSelf-citationWilsey, B. L., Deutsch, R., & Marcotte, T. D. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0016 · Cited by 32
“The dilemma of not using a placebo is avoided in comparative effectiveness research (CER), which delivers active treatment to all participants.(18) CER trials are a particular focus for the National Institutes of Health.”
BackgroundThe impact of explicit mental health messages in video games on players’ motivation and affect
Poppelaars, M., Lichtwarck‐Aschoff, A., Kleinjan, M., & Granic, I. (2018) · Computers in Human Behavior · doi:10.1016/j.chb.2018.01.019 · Cited by 33
Complementary and alternative drug therapy versus science-oriented medicine
Anlauf, M., Hein, L., Hense, H., Köbberling, J., Lasek, R., Leidl, R., & Schöne-Seifert, B. (2015) · PubMed Central · doi:10.3205/000209 · Cited by 42
“It is expected that individual (“customised”) placebo responses will play a bigger role in therapeutic practice in the future while considering genetic disposition, individual medical history and other factors [140].”
BackgroundHow Positive and Negative Expectations Shape the Experience of Visceral Pain
Elsenbruch, S. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_6 · Cited by 27
“This is paralleled by more refined knowledge regarding the conceptualization, design, and analysis of clinical trials (Enck et al. 2013; Rief et al. 2011).”
BackgroundHigh-dose thiamine improves the symptoms of fibromyalgia
Costantini, A., Pala, M. I., Tundo, S., & Matteucci, P. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-009019 · Cited by 26
Why we need more research into the placebo response in psychiatry
Huneke, N. T. M., van der Wee, N. J. A., Garner, M. J., & Baldwin, D. S. (2020) · Psychological Medicine · doi:10.1017/s0033291720003633 · Cited by 28
“One possibility to overcome this could be to use novel trial designs, such as a modified Zelen design, in which participants could be recruited to an observational study and a random sub-group then approached to participate in a clinical trial (Enck et al., 2013; Zelen, 1979).”
BackgroundMethodInfluentialOddsson, L., Bisson, T. A., Cohen, H. S., Jacobs, L., Khoshnoodi, M. A., Kung, D. H., Lipsitz, L. A., Manor, B. D., McCracken, P., Rumsey, Y., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.592751 · Cited by 28
Translating knowledge on placebo and nocebo effects into clinical practice
Caliskan, E., Bingel, U., & Kunkel, A. (2024) · PAIN Reports · doi:10.1097/pr9.0000000000001142 · Cited by 25
Self-citationPhasic and Tonic Pain Differentially Impact the Interruptive Function of Pain
Sinke, C., Schmidt, K., Forkmann, K., & Bingel, U. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118363 · Cited by 33
“It is well known that positive and negative expectations can increase or reduce the perception of pain, as best illustrated in placebo or nocebo paradigms [35,36].”
BackgroundSelf-citationThe Application of Persuasion Theory to Placebo Effects
Geers, A. L., Briñol, P., Vogel, E. A., Aspiras, O. G., Caplandies, F. C., & Petty, R. E. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.01.004 · Cited by 31
Expectancy Modulation of Opioid Neurotransmission
Peciña, M., & Zubieta, J.-K. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.02.003 · Cited by 29
Placebo Effect: Theory, Mechanisms and Teleological Roots
Hashmi, J. A. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.017 · Cited by 25
Assessing the Impact of Expectations in Cognitive Training and Beyond
Denkinger, S., Spano, L. P., Bingel, U., Witt, C. M., Bavelier, D., & Green, C. S. (2021) · Journal of Cognitive Enhancement · doi:10.1007/s41465-021-00206-7 · Cited by 27
Self-citationSedaño, R., Hogan, M., Nguyen, T. M., Chang, J., Zou, G., MacDonald, J. K., Casteele, N. V., Hanžel, J., Crowley, E., Battat, R. J., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab135 · Cited by 27
Prospects of Disease-Modifying Osteoarthritis Drugs
Oo, W. M. (2022) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.11.010 · Cited by 28
Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms
Buergler, S., Sezer, D., Bagge, N., Kirsch, I., Locher, C., Carvalho, C., & Gaab, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-29624-7 · Cited by 27
“Participants were (1) reminded of the importance of this group, (2) asked about the nature of their exam, (3) about their problem (i.”
BackgroundMethodInfluentialAre Children the Better Placebo Analgesia Responders? An Experimental Approach
Wrobel, N., Fadai, T., Sprenger, C., Hebebrand, J., Wiech, K., & Bingel, U. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.06.013 · Cited by 26
Self-citationDo placebo expectations influence perceived exertion during physical exercise?
Mothes, H., Leukel, C., Seelig, H., & Fuchs, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180434 · Cited by 25
van Middendorp, H., Kox, M., Pickkers, P., & Evers, A. W. M. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-3009-8 · Cited by 25
Placebo effects in obesity research
Fontaine, K. R., Williams, M. S., Hoenemeyer, T. W., Kaptchuk, T. J., & Dutton, G. R. (2016) · Obesity · doi:10.1002/oby.21456 · Cited by 26
“In addition, conveying information that creates expectations for success, in conjunction with one’s desire to improve, can enhance the therapeutic response (1-5,9).”
Geisler, M., Herbsleb, M., Bär, K., & Weiß, T. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.553530 · Cited by 32
Motta, L. S., Gosmann, N. P., Costa, M. D. A., Jaeger, M. D. B., Frozi, J., Grevet, L. T., Spanemberg, L., Manfro, G. G., Cuijpers, P. J., Pine, D. S., et al. (2023) · BMJ Mental Health · doi:10.1136/bmjment-2022-300630 · Cited by 25
Pedersen, J. R., Strijkers, R., Gerger, H., Koes, B. W., & Chiarotto, A. (2024) · Pain · doi:10.1097/j.pain.0000000000003151 · Cited by 31
Neurobehavioral consequences of small molecule-drug immunosuppression
Bösche, K., Weißenborn, K., Christians, U., Witzke, O., Engler, H., Schedlowski, M., & Hadamitzky, M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.008 · Cited by 29
Self-citationDuijvestein, M., Jeyarajah, J., Guizzetti, L., Zou, G., Parker, C. E., van Viegen, T., Casteele, N. V., Khanna, R., der Aa, A. V., Sandborn, W. J., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.08.025 · Cited by 25
Sochacki, K. R., Mather, R. C. “., Nwachukwu, B. U., Dong, D., Nho, S. J., Cote, M. P., & Harris, J. D. (2020) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2020.05.001 · Cited by 28
Keefe, J. R., Amsterdam, J. D., Li, Q. S., Soeller, I., DeRubeis, R. J., & Mao, J. J. J. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.09.029 · Cited by 24
“…disciplines, prior studies have frequently measured patients' general health optimism or pessimism rather than their expectancy that a particular treatment would be helpful for their condition or be likely to cause side effects (Barefoot et al., 2011; Enck et al., 2013; Nestoriuc et al., 2010).”
BackgroundRole of placebo effects in pain and neuropsychiatric disorders
Belcher, A. M., Ferré, S., Martinez, P. E., & Colloca, L. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.003 · Cited by 28
Accounting for Behavior in Treatment Effects: New Applications for Blind Trials
Chassang, S., Snowberg, E., Seymour, B., & Bowles, C. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127227 · Cited by 27
“effects include the therapeutic effects of such (unconscious or conscious) behavior changes [5], and negative effects, although possibly less common, are called nocebo effects [6, 7].”
BackgroundChanging perceptions and efficacy of generic medicines: An intervention study.
Colgan, S., Faasse, K., Pereira, J. A., Grey, A. B., & Petrie, K. J. (2016) · Health Psychology · doi:10.1037/hea0000402 · Cited by 25
Laferton, J. A. C., Vijapura, S., Baer, L., Clain, A. J., Cooper, A. R., Papakostas, G. I., Price, L. H., Carpenter, L. L., Tyrka, A. R., Fava, M., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00424 · Cited by 25
“To better understand (1) whether the perception of the treatment assignment changes over the course of a study, (2) and whether these changes are influenced by side effects or health improvement, and (3) whether the perceived treatment assignment is prospectively related to the treatment effects, a reanalysis of a thr…”
BackgroundDrug‐Placebo Additivity in Randomized Clinical Trials
Hall, K. T., & Loscalzo, J. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1626 · Cited by 25
Almradi, A., Sedaño, R., Hogan, M., Zou, G., MacDonald, J. K., Parker, C. E., Hanžel, J., Crowley, E., Singh, S., D’Haens, G., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab194 · Cited by 24
Sondermann, W., Jockenhöfer, F., Dissemond, J., Pfaar, O., Bingel, U., & Schedlowski, M. (2021) · Dermatology · doi:10.1159/000513445 · Cited by 24
Self-citationSaleem, S., Aziz, M., Khan, A. A., Williams, M.-J., Mathur, P., Tansel, A., Barber, A. E., & Abell, T. L. (2022) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2022.10.048 · Cited by 22
Prompiengchai, S., & Dunlop, K. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01907-1 · Cited by 25
Bolten, W. W., Glade, M. J., Raum, S., & Ritz, B. W. (2015) · Arthritis · doi:10.1155/2015/251521 · Cited by 22
“The value of such studies is limited because it is not possible to discern the additional benefits of the enzyme combination beyond the well-established influence of placebo on subjective measures of joint pain [28, 29].”
BackgroundSchwartz, M., Fischer, L., Bläute, C., Stork, J., Colloca, L., Zöllner, C., & Klinger, R. (2021) · Pain · doi:10.1097/j.pain.0000000000002513 · Cited by 26
Masurovsky, A. (2020) · JMIR Serious Games · doi:10.2196/14030 · Cited by 24
“For instance, a warm and caring demeanor on the part of the clinician administering medication may interact with the chemical components of the medication itself to produce an even stronger reduction in the patient’s subjective experience of pain [25].”
BackgroundThe magnitude of placebo analgesia effects depends on how they are conceptualized
Lund, K., Petersen, G. L., Erlandsen, M., De Pascalis, V., Vase, L., Jensen, T. S., & Finnerup, N. B. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.05.002 · Cited by 18
Fageera, W., Traicu, A., Sengupta, S. M., Fortier, M., Choudhry, Z., Labbe, A., Grizenko, N., & Joober, R. (2017) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1572 · Cited by 24
Methods for assessing and controlling placebo effects
Kessels, R., Mozer, R., & Bloemers, J. (2017) · Statistical Methods in Medical Research · doi:10.1177/0962280217748339 · Cited by 20
Lückemann, L., Stangl, H., Straub, R. H., Schedlowski, M., & Hadamitzky, M. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41101 · Cited by 21
“The application of learned immunopharmacologic strategies in clinical situations as supportive therapy together with standard pharmacologic regimens has been suggested (4,5,45).”
BackgroundSelf-citationMeeuwis, S. H., van Middendorp, H., van Laarhoven, A. I. M., van Leijenhorst, C., Pacheco‐López, G., Lavrijsen, A. P. M., Veldhuijzen, D. S., & Evers, A. W. M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.03.025 · Cited by 24
“, 2011), could be considered most directly applicable in clinical practice (Enck et al., 2013), and has been found to be as effective as full medication doses – not just in psoriasis, but also in other conditions such as attention-deficit hyperactivity disorder (Ader et al.”
Mostafaei, H., Janisch, F., Mori, K., Quhal, F., Pradère, B., Hajebrahimi, S., Roehrborn, C. G., & Shariat, S. F. (2021) · European Urology Focus · doi:10.1016/j.euf.2021.02.005 · Cited by 21
The beneficial effect of positive treatment expectations on pharmacological migraine prophylaxis
Schmidt, K., Berding, T., Kleine‐Borgmann, J., Engler, H., Holle, D., Gaul, C., & Bingel, U. (2021) · Pain · doi:10.1097/j.pain.0000000000002341 · Cited by 21
Self-citationComparison of veterinary drugs and veterinary homeopathy: part 1
Lees, P., Pelligand, L., Whiting, M. C., Chambers, D., Toutain, P., & Whitehead, M. L. (2017) · Veterinary Record · doi:10.1136/vr.104278 · Cited by 22
Matsingos, A., Wilhelm, M., Noor, L., Yildiz, C., Rief, W., Hofmann, S. G., Falkenberg, I., & Kircher, T. T. J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1346697 · Cited by 27
Self-citationApplications and limitations of behaviorally conditioned immunopharmacological responses
Lückemann, L., Unteroberdörster, M., Kirchhof, J., Schedlowski, M., & Hadamitzky, M. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.02.012 · Cited by 22
Self-citationDoes the model of additive effect in placebo research still hold true? A narrative review
Boehm, K., Berger, B., Weger, U., & Heusser, P. (2017) · JRSM Open · doi:10.1177/2054270416681434 · Cited by 22
“Other research teams suggest an alternative to the additive model: the interactive model, which assumes that drug-specific effects may interact with the placebo responses to result in unequal placebo effects in the two study groups.(21) Psychological and physical effects may interact with one another, and thus researc…”
BackgroundPalermo, S., Giovannelli, F., Bartoli, M., & Amanzio, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00502 · Cited by 22
“stated 2012, specific strategies to reduce nocebo effects should be further developed in clinical trials and practice to minimize these symptoms (Enck et al., 2013), also considering patients with SCD.”
BackgroundInfluentialRossettini, G., Geri, T., Palese, A., Marzaro, C., Mirandola, M., Colloca, L., Fiorio, M., Turolla, A., Manoni, M., & Testa, M. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.582174 · Cited by 24
Bagnis, A., Meeuwis, S. H., Haas, J. W., O’Keeffe, M., Bajcar, E. A., Bąbel, P., Evers, A. W. M., Glogan, E., Oleszczyk, M., Portolés, A., et al. (2025) · Health Psychology Review · doi:10.1080/17437199.2025.2471792 · Cited by 21
“…response has been de fi ned as the positive health outcome of a patient that occurs following an inert treatment (e.g., a placebo pill) and it includes placebo e ff ects, but also other non-speci fi c factors, such as the natural course of disease (Enck et al., 2013; Evers et al., 2018; Kelley, 2018).”
InfluentialStuhlreyer, J., Roder, C., Krug, F., Zöllner, C., Flor, H., & Klinger, R. (2022) · BMC Medicine · doi:10.1186/s12916-022-02638-0 · Cited by 26
Prospects of Disease-Modifying Osteoarthritis Drugs
Oo, W. M. (2024) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2024.03.003 · Cited by 20
Symptom dynamics during repeated serial allergen challenge chamber exposures to house dust mite
Jacobs, R. L., Andrews, C. P., Ramirez, D., Rather, C. G., Harper, N., Jiménez, F., Martinez, H. G., Manoharan, M. S., Carrillo, A., Gerardi, M. B., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.09.047 · Cited by 19
Knowledge Gaps in Placebo Research: With Special Reference to Neurobiology
Enck, P., Horing, B., Broelz, E. K., & Weimer, K. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.018 · Cited by 20
Self-citationBernstein, M. H., Locher, C., Κube, T., Buergler, S., Stewart‐Ferrer, S., & Blease, C. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.01354 · Cited by 21
Stalujanis, E., Neufeld, J., Stalder, M. G., Belardi, A., Tegethoff, M., & Meinlschmidt, G. (2020) · JMIR mhealth and uhealth · doi:10.2196/20329 · Cited by 21
“In the field of placebo research, there are situations in which placebo effects should be diminished and others in which placebo effects should be enhanced [15,21].”
Locher, C., Buergler, S., Nascimento, A. F., Kost, L., Blease, C., & Gaab, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053346 · Cited by 21
Placebo Effects and Neuromodulation: Ethical Considerations and Recommendations
Mollica, A., Greben, R., Cyr, M., Olson, J. A., & Burke, M. J. (2023) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2023.24 · Cited by 20
Sandra, D. A., Olson, J. A., Langer, E. J., & Roy, M. (2023) · eLife · doi:10.7554/elife.84691 · Cited by 20
Practitioner warmth and empathy attenuates the nocebo effect and enhances the placebo effect
Barnes, K., Wang, R., & Faasse, K. (2023) · Applied Psychology Health and Well-Being · doi:10.1111/aphw.12497 · Cited by 21
Lessons to be Learned from Placebo Arms in Psychopharmacology Trials
Doering, B. K., Rief, W., & Petrie, K. J. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-44519-8_15 · Cited by 19
Self-citationThe role of placebo in the diagnosis and treatment of functional neurologic disorders
Rommelfanger, K. S. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801772-2.00049-7 · Cited by 20
Kampermann, L., Nestoriuc, Y., & Mora, M. C. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178719 · Cited by 18
The placebo and its effects: A psychoneuroendocrinological perspective
Gaab, J. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.08.008 · Cited by 19
Placebo hypoalgesia: above and beyond expectancy and conditioning
Okusogu, C., & Colloca, L. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.10.008 · Cited by 20
“suggested enhancing the doctor-patient interaction by promoting respectful, meaningful, and collaborative discussion between the two parties involved is of the upmost importance when maximizing placebo effects, while minimizing nocebo effects [46].”
Association of nocebo hyperalgesia and basic somatosensory characteristics in a large cohort
Feldhaus, M. H., Horing, B., Sprenger, C., & Büchel, C. (2021) · Scientific Reports · doi:10.1038/s41598-020-80386-y · Cited by 21
Sölle, A., Worm, M., Benedetti, F., Bartholomäus, T., Schwender‐Groen, L., & Klinger, R. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2276 · Cited by 20
Göhler, A. C., Haas, J. W., Sperl, M. F. J., Hermann, C., & Winkler, A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.037 · Cited by 19
Ardito, R. B., Pirro, P. S., Re, T. S., Bonapace, I., Menardo, V., Bruno, E., & Gianotti, L. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2016.0423 · Cited by 17
Hendrickson, R. C., Thomas, R. G., Schork, N. J., & Raskind, M. A. (2020) · Frontiers in Digital Health · doi:10.3389/fdgth.2020.00013 · Cited by 17
“In fact, such interactive effects between biologic response, non-treatmentspecific effects, and even augmenting treatments are often explicitly hoped for and pursued in the context of routine clinical care (37), where a psychiatrist may e.”
BackgroundLückemann, L., Bösche, K., Engler, H., Schwitalla, J. C., Hadamitzky, M., & Schedlowski, M. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.005 · Cited by 18
“…to minimize the amount of drugs and thereby decreasing adverse drug side effects and maximize the therapeutic outcome for the patient’s benefit (Ader et al., 2010; Colloca and Benedetti, 2005; Doering and Rief, 2012; Enck et al., 2013; Schedlowski and Pacheco-Lopez, 2010; Schedlowski et al., 2015).”
BackgroundSelf-citationHadidi, Y. N. E., Kassaby, M. E., Fattah, S. A. E., & Khamis, N. S. (2016) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2016.03.021 · Cited by 17
Preserved Capacity for Placebo Analgesia in the Elderly
Wrobel, N., Fadai, T., Brassen, S., & Bingel, U. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.08.012 · Cited by 18
Self-citationLückemann, L., Unteroberdörster, M., Gomez, E. M., Schedlowski, M., & Hadamitzky, M. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.013 · Cited by 17
Self-citationVachon‐Presseau, É., Abdullah, T. B., Berger, S., Huang, L., Griffith, J. W., Schnitzer, T. J., & Apkarian, A. V. (2021) · Pain · doi:10.1097/j.pain.0000000000002450 · Cited by 18
High-Dose Thiamine Improves Fatigue After Stroke: A Report of Three Cases
Costantini, A., Pala, M. I., Catalano, M. L., Notarangelo, C., & Careddu, P. (2014) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2013.0461 · Cited by 17
“The lack of a control group makes the results preliminary and more difficult to interpret.(6)”
ResultWeimer, K., Hahn, E., Mönnikes, N. J., Herr, A.-K., Stengel, A., & Enck, P. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00679 · Cited by 20
“Neither of these approaches has been able to allow the precise identification of placebo responders (1, 2).”
BackgroundSelf-citationSurgical treatment for migraine: Time to fight against the knife
Diener, H., & Bingel, U. (2014) · Cephalalgia · doi:10.1177/0333102414545895 · Cited by 17
Self-citationEffects of Open-Label Placebos on State Anxiety and Glucocorticoid Stress Responses
Schaefer, M., Hellmann‐Regen, J., & Enge, S. (2021) · Brain Sciences · doi:10.3390/brainsci11040508 · Cited by 18
“Furthermore, contextual factors such as narratives, instructions, positive expectations, and interactions with healthcare providers are known to interact with an individual patient’s characteristics, which may also include genetics as well as the experienced medical history [9,55,56].”
BackgroundPlacebo effects on nausea and motion sickness are resistant to experimentally-induced stress
Jacob, C., Olliges, E., Haile, A., Hoffmann, V. S., Jacobi, B., Steinkopf, L., Lanz, M., Wittmann, M., Tschöp, M. H., & Meißner, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-36296-w · Cited by 18
Metadata
- Authors
- Enck, P., Bingel, U., Schedlowski, M., & Rief, W.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Essen University Hospital (DE)
- Philipps University of Marburg (DE)
- Corresponding author
- Enck, Paul
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-03
- Volume
- 12
- Issue
- 3
- Pages
- 191-204
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2062838995
- Cited by
- 671
- References
- 168
- Citations by year
- 2026: 32 · 2025: 53 · 2024: 45 · 2023: 50 · 2022: 41 · 2021: 51 · 2020: 58 · 2019: 53 · 2018: 63 · 2017: 54 · 2016: 51 · 2015: 47 · 2014: 50 · 2013: 23
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- placebo response, placebo effect, drug development, clinical trials, patient expectations, learning mechanisms, personalized medicine, genetic susceptibility, drug efficacy
- MeSH terms
- Clinical Trials as Topic, Humans, Physician-Patient Relations, Drug Design, Placebo Effect, Treatment Outcome, Drug Discovery, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.